GlassScriptPhysician profile
Brandon Mcduffie
NPI 1225289168
$2,644.51
in general payments reported to CMS, 2019-2025
20 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $908 · 2022: $977 · 2023: $282 · 2024: $284 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.42 |
| Education | $183.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $395.58 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $379.19 | 2021-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $357.89 | 2021-2022 | |
| Pfizer INC. | $339.08 | 2021-2025 | |
| Journey Medical Corporation | $289.54 | 2021-2022 | |
| Dermavant Sciences, INC. | $208.90 | 2023-2024 | Vtama |
| Janssen Biotech, INC. | $135.78 | 2021-2022 | |
| Genzyme Corporation | $130.57 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $90.94 | 2021-2022 | |
| Leo Pharma INC. | $48.55 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $44.31 | 2022-2024 | Sotyktu |
| Botanix Sb INC | $41.50 | 2025 | Sofdra |
| Amgen INC. | $40.18 | 2021-2022 | |
| Galderma Laboratories, L.P. | $34.27 | 2021-2025 | Nemluvio |
| Ucb, INC. | $23.36 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $22.38 | 2021 | |
| Sandoz INC. | $21.93 | 2023 | |
| Lilly USA, LLC | $19.98 | 2021 | |
| Arcutis Biotherapeutics, INC. | $14.44 | 2025 | Zoryve |
| Organon LLC | $6.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Mcduffie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.